V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240014107 | 240008103 | 1.8 | null | Curative (C) | 2018-08-04 | 2018-11-19 | Bendamustine +/- Prednisolone | N | N | 240033009 | LENALIDOMIDE |
| 240014108 | 240012340 | 1.77 | null | Palliative (P) | 2015-06-19 | 2015-07-11 | Methotrexate High Dose (3g/m2) | N | null | 240033048 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 240014109 | 240012342 | 1.75 | 99.6 | Curative (C) | 2019-11-07 | 2019-11-07 | BENDAMUSTINE | N | N | 240033057 | METHOTREXATE HIGH DOSE |
| 240014110 | 240008109 | 1.69 | null | Palliative (P) | 2016-11-12 | 2016-11-25 | R Chlorambucil | N | N | 240033064 | CHLORAMBUCIL + RITUXIMAB |
| 240014111 | 240008109 | null | 79.9 | Palliative (P) | 2014-11-20 | 2014-11-20 | Methotrexate High Dose (3g/m2) | 2 | N | 240033064 | BORTEZOMIB |
| 240014112 | 240008112 | null | null | Palliative (P) | 2013-10-16 | 2013-10-17 | R IVAC | N | null | 240033085 | GEMCARBO |
| 240014113 | 240008113 | 1.51 | 0 | Curative (C) | 2013-12-09 | 2013-12-09 | CHLORAMBUCIL + RITUXIMAB | N | N | 240033086 | CHLORAMBUCIL + RITUXIMAB |
| 240014114 | 240008113 | 1.63 | 99.5 | Neo-adjuvant (N) | 2017-03-17 | 2017-03-22 | Cytarabine Low Dose | 02 | null | 240033086 | METHOTREXATE |
| 240014115 | 240014337 | 1.67 | 55 | Disease modification (D) | 2015-01-01 | 2015-01-04 | METHOTREXATE | null | null | 240033090 | BENDAMUSTINE |
| 240014116 | 240008117 | 1.82 | 55.2 | null | 2014-03-20 | 2014-03-21 | R Chlorambucil | N | N | 240033101 | CHLORAMBUCIL + RITUXIMAB |
| 240014117 | 240008119 | null | 0 | Palliative (P) | 2017-12-19 | 2017-12-20 | METHOTREXATE | 2 | N | 240033104 | CISPLATIN + ETOPOSIDE |
| 240014118 | 240008121 | 1.69 | 89.6 | Palliative (P) | 2019-01-01 | 2019-01-15 | Cisplatin + Topotecan | N | N | 240033117 | GEMCARBO |
| 240014119 | 240015858 | 1.69 | 59 | Palliative (P) | null | 2017-07-11 | GDP | N | N | 240033120 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 240014120 | 240008124 | 0 | 117 | Palliative (P) | 2018-06-11 | 2018-06-18 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | N | 240033150 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 240014121 | 240015349 | 1.74 | null | Curative (C) | 2017-10-10 | 2017-10-10 | METHOTREXATE | 2 | N | 240033173 | GEMCITABINE |
| 240014122 | 240008125 | 1.81 | 83.2 | Disease modification (D) | 2015-07-16 | 2015-07-30 | Chlorambucil | N | null | 240033179 | CHLORAMBUCIL |
| 240014123 | 240014341 | 1.68 | 79.4 | Curative (C) | 2017-09-07 | 2018-03-31 | Cyclophosphamide High Dose | 2 | N | 240033188 | CYTARABINE |
| 240014124 | 240008128 | 1.58 | 46.9 | Disease modification (D) | null | 2015-09-08 | Chlorambucil | N | N | 240033190 | CHLORAMBUCIL |
| 240014125 | 240008130 | 1.85 | 61.2 | Curative (C) | 2016-07-21 | 2017-03-25 | Brentuximab | 02 | N | 240033214 | BRENTUXIMAB |
| 240014126 | 240008132 | 1.78 | null | Palliative (P) | 2015-05-23 | 2015-05-27 | GEMCITABINE | 2 | N | 240033236 | IBRUTINIB |
| 240014127 | 240008134 | 1.61 | 110 | Palliative (P) | 2015-02-20 | 2015-02-24 | Cytarabine Low Dose | 2 | null | 240033241 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 240014128 | 240008137 | 1.58 | null | Neo-adjuvant (N) | 2016-01-20 | 2016-01-31 | Methotrexate High Dose (3g/m2) | 02 | N | 240033254 | GDP |
| 240014129 | 240008139 | 1.54 | null | Curative (C) | 2017-06-07 | 2017-06-28 | CISPLATIN + ETOPOSIDE | 02 | null | 240033266 | R IVAC |
| 240014130 | 240012359 | 1.72 | null | Disease modification (D) | 2016-06-20 | 2016-11-02 | Methotrexate High Dose (3g/m2) | N | N | 240033268 | ABVD |
| 240014131 | 240008142 | 1.64 | 124.4 | null | 2016-04-27 | 2016-05-10 | FLAG + Idarubicin | N | N | 240033272 | CISPLATIN + TOPOTECAN |
| 240014132 | 240008149 | 1.45 | 75.8 | Palliative (P) | 2016-01-03 | 2016-01-04 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | N | 240033298 | CARBOPLATIN + ETOPOSIDE |
| 240014133 | 240008150 | 1.57 | 72 | Curative (C) | 2013-07-30 | 2013-07-31 | Methotrexate High Dose (3g/m2) | 02 | N | 240033308 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 240014134 | 240008152 | 1.66 | 65 | Palliative (P) | 2014-10-15 | 2014-11-04 | Trastuzumab Subcutaneous | 02 | N | 240033321 | METHOTREXATE HIGH DOSE |
| 240014135 | 240008153 | 1.73 | 59 | Curative (C) | 2017-08-03 | 2017-08-03 | Cisplatin + Topotecan | N | null | 240033322 | CISPLATIN + ETOPOSIDE |
| 240014136 | 240008156 | 1.64 | null | Curative (C) | 2013-12-24 | 2014-01-01 | BENDAMUSTINE | 2 | N | 240033348 | BEAM |
| 240014137 | 240008158 | 1.56 | 58.8 | Curative (C) | 2014-03-16 | 2014-03-16 | IBRUTINIB | N | N | 240033356 | BENDAMUSTINE |
| 240014138 | 240008161 | 1.78 | 0 | Disease modification (D) | 2016-03-26 | 2016-07-05 | Cytarabine Low Dose | N | Y | 240033387 | DA |
| 240014139 | 240012372 | 1.81 | 87.2 | Curative (C) | 2016-02-27 | 2016-02-27 | LENALIDOMIDE | 02 | N | 240033393 | FCR |
| 240014140 | 240014351 | null | 75 | Palliative (P) | 2018-09-03 | 2018-09-04 | BEAM | n | null | 240033397 | METHOTREXATE |
| 240014141 | 240015861 | 1.7 | 99.8 | Disease modification (D) | 2015-11-02 | 2015-11-03 | Trastuzumab Subcutaneous | N | N | 240033415 | ABVD |
| 240014142 | 240008167 | 1.63 | 81.8 | Palliative (P) | 2019-05-31 | 2019-07-06 | BEAM | 02 | N | 240033450 | CYCLOPHOSPHAMIDE |
| 240014143 | 240008168 | null | 51 | Adjuvant (A) | 2017-05-28 | 2017-06-05 | FCR Oral - Cycle 1 | N | N | 240033451 | LENALIDOMIDE |
| 240014145 | 240008172 | 1.62 | 111.1 | Palliative (P) | null | 2014-03-04 | GEMCITABINE | 02 | n | 240033485 | CARBOPLATIN + ETOPOSIDE |
| 240014146 | 240008175 | 1.77 | 99.5 | Disease modification (D) | 2016-04-30 | 2016-04-30 | Cyclophosphamide High Dose | N | N | 240033486 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240014147 | 240008179 | 1.62 | 77.1 | Curative (C) | 2018-04-17 | 2018-04-21 | CARBOPLATIN + ETOPOSIDE | N | N | 240033516 | R IVAC |
| 240014148 | 240008179 | null | null | Curative (C) | 2018-10-23 | 2018-10-23 | BENDAMUSTINE | N | N | 240033516 | HYDROXYCARBAMIDE |
| 240014149 | 240008181 | 1.78 | 108.7 | Adjuvant (A) | 2017-07-20 | 2017-07-20 | Carboplatin + Etoposide IV 3 day | 2 | null | 240033519 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240014150 | 240008182 | null | null | Palliative (P) | 2016-02-12 | 2016-02-26 | R Chlorambucil | 02 | null | 240033523 | CHLORAMBUCIL + RITUXIMAB |
| 240014151 | 240008183 | 1.6 | null | null | 2015-01-15 | 2015-01-22 | FLAG + Idarubicin | 02 | N | 240033526 | BORTEZOMIB |
| 240014152 | 240008184 | null | 101 | Disease modification (D) | 2013-11-06 | 2013-11-08 | Cisplatin + Topotecan | N | N | 240033543 | BENDAMUSTINE |
| 240014153 | 240008188 | 1.82 | 63.5 | Palliative (P) | 2014-07-26 | 2014-08-29 | R IVAC | N | N | 240033545 | DHAP |
| 240014154 | 240016126 | 1.62 | 46.9 | Palliative (P) | 2015-04-19 | 2015-04-23 | R Chlorambucil | N | N | 240033562 | CHLORAMBUCIL + RITUXIMAB |
| 240014155 | 240008190 | 0 | 48.4 | Curative (C) | 2015-10-07 | 2015-10-09 | ABVD | N | N | 240033568 | LENALIDOMIDE |
| 240014156 | 240008192 | 1.69 | 64.1 | Curative (C) | 2016-07-06 | 2016-07-06 | Carboplatin + Etoposide IV 3 day | N | N | 240033580 | CISPLATIN + TOPOTECAN |
| 240014157 | 240008196 | 1.54 | 105 | Curative (C) | 2017-01-01 | 2017-01-01 | CYCLOPHOSPHAMIDE | N | null | 240033602 | CYTARABINE |